SGLT2 inhibitor use in the management of feline diabetes mellitus
Journal of Veterinary Pharmacology and Therapeutics · 2025-01 · 48 (S1) · 19-30
DOI: 10.1111/jvp.13466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 02.07.2024. Verfasst von Audrey K Cook und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, U…. Hauptthemen laut MEDLINE: Cat Diseases, Sodium-Glucose Transporter 2 Inhibitors, Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors are routinely used in the management of human type 2 diabetes and have been shown to effectively mitigate hyperglycemia and reduce the risks of cardiovascular and renal compromise. Two SGLT2 inhibitors, namely bexagliflozin and velagliflozin, were recently FDA approved for the treatment of uncomplicated feline diabetes mellitus. These oral hypoglycemic agents are a suitable option for many newly diagnosed cats, with rapid improvements in glycemic control and clinical signs. Suitable candidates must have some residual β‐cell function, as some endogenous insulin production is required to prevent ketosis. Appropriate patient selection and monitoring are necessary, and practitioners should be aware of serious complications such as euglycemic diabetic ketoacidosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
- Veterinary Information Network, Davis, California, USA.
ORCID-Profile: Audrey K Cook, Ellen Behrend
Zitieren
APA
Cook, A. K., & Behrend, E. (2025). SGLT2 inhibitor use in the management of feline diabetes mellitus. Journal of Veterinary Pharmacology and Therapeutics, 48(S1), 19-30. https://doi.org/10.1111/jvp.13466
Vancouver
Cook AK, Behrend E. SGLT2 inhibitor use in the management of feline diabetes mellitus. Journal of Veterinary Pharmacology and Therapeutics. 2025;48(S1):19-30. doi:10.1111/jvp.13466
BibTeX
@article{Cook2025,
author = {Cook, Audrey K and Behrend, Ellen},
title = {SGLT2 inhibitor use in the management of feline diabetes mellitus},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2025},
volume = {48},
number = {S1},
pages = {19--30},
doi = {10.1111/jvp.13466}
}
EUVIMED